The National Chairman, Association of Industrial Pharmacists of Nigeria, Ignatius Anukwu, says the local pharmaceutical industry can produce many products of indigenous research that will not only meet the medical needs of Nigerians but also compete favourably in the international space.

To achieve this objective, Anukwu said, the nation must bridge the huge infrastructural and skills gaps in drug manufacturing by establishing pharmaceutical manufacturing parks where drug research and manufacturing can take place with less difficulty.

The NAIP, he said, is committed to consolidating the gains made in its advocacy for the establishment of the parks as effective means of bridging these gaps.

In his address at the 23rd annual national conference of the NAIP, held in Kano recently, Anukwu said the association was already in discussion with key stakeholders to realise the objective, noting that the pharmaceutical parks will be one-stop shops providing numerous services to address the needs of the pharmaceutical industry.

Members of the association, he said, are working hard for the realisation of the pharmaceutical parks idea in Nigeria, noting that it is where high quality finished pharmaceutical products and active pharmaceutical ingredients will be produced.

“Parks with WHO Current Good Manufacturing Practice- compliant facilities, where a centre of excellence for research and development would be at the heart of indigenous pharmaceutical research efforts.

“Parks where strategic workforce development for present and future generation of industrial pharmacists would be shaped to play their roles more effectively,” Anukwu said.

He disclosed further that the parks will bring all key stakeholders together including government, academia, professionals and the private sector, adding that working together these stakeholders would help revolutionalise local drug manufacturing and reposition Nigeria to benefit from freer trade on the continent while also increasing drug exports.

The parks, Anukwu added would not only help in the local production of premium health products but ensure they are easily accessible and affordable for the citizens.

He said, it would also help create a more resilient medicine supply chain that is less vulnerable to external shocks and other eventualities thus ensuring medicine security and sustainability in the supply chain.



Comment Here

By PharmaTimes

PharmaTimes offers a unique blend of health stories, interviews, features, covering all aspects of health as it affects every individual and mankind.

Leave a Reply

Your email address will not be published.